| Ytd | -3.67% | |
| 1y | -4.55% |
| Open | 1.06 | Prev Close | 1.07 | Low | 1.04 | High | 1.09 | Mkt Cap | 200.31M |
| Vol | 642.77K | Avg Vol | 1.17M | EPS | -0.34 | P/E | N/A | Forward P/E | -1.12 |
| Beta | 1.42 | Short Ratio | 0.80 | Inst. Own | 4.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.04 | 200-d Avg | 1.15 | 1yr Est | 3.50 |
Lucid Diagnostics reported Q1 revenue miss. Analyst significant expects revenue growth in 2026/27. R
Ascendiant Capital analyst Edward Woo maintains Lucid Diagnostics (NASDAQ:LUCD) with a Buy and ra